Enhanced offering gives hospitals flexibility to automate scan sequences from leading vendors into one scan protocol
News | Magnetic Resonance Imaging (MRI)
HeartVista, Siemens Healthineers Sign Commercial Agreement to Bring AI-Driven Image Acquisition to Hospital MRI Scanners

November 17, 2022 — HeartVista, a pioneer in AI-assisted MRI solutions, and Siemens Healthineers, a global leader in ...

Home November 17, 2022
Home
Adds natural language processing to Viz.ai’s AI-powered platform to detect suspected disease earlier and monitor patients
News | Artificial Intelligence
Viz.ai Partners with Illuminate to Improve Quality of Care for Aortic Aneurysm Patients

November 16, 2022 — Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today ...

Home November 16, 2022
Home
Osso VR, now the largest and fastest-growing virtual reality (VR) company in healthcare, and the American College of Cardiology (ACC), a global nonprofit dedicated to transforming cardiovascular care, today announced a new collaboration to develop an immersive, VR-enabled training program for cardiovascular professionals.
News | Virtual and Augmented Reality
Osso VR and American College of Cardiology to Develop Immersive Training for Cardiovascular Professionals

November 16, 2022 — Osso VR, now the largest and fastest-growing virtual reality (VR) company in healthcare, and the ...

Home November 16, 2022
Home
An AI algorithm applied to Apple Watch ECG recordings successfully identified a weak heart pump in patients
News | Artificial Intelligence
AI Transforms Smartwatch ECG Signals Into a Diagnostic Tool for Heart Failure

November 16, 2022 — A study published in Nature Medicine reports the ability of a smartwatch ECG to accurately detect ...

Home November 16, 2022
Home
Certain adults with this artery-blocking condition may see more benefits with an open bypass compared to less-invasive procedures to improve circulation.
News | Peripheral Artery Disease (PAD)
Bypass Surgery Favorable for Initial Treatment of Chronic Limb-Threatening Ischemia

November 15, 2022 Performing open bypass surgery to restore circulation for people with a severe form of peripheral ...

Home November 15, 2022
Home
Edwin A. Takahashi, M.D., assistant professor of radiology in the division of interventional radiology at the Mayo Clinic College of Medicine in Rochester, Minnesota. Copyright Mayo Clinic College of Medicine
News | AHA
Telehealth is a Valuable Option in Cardiovascular Care, Though Challenges Remain

November 15, 2022 — Telehealth is a proven and valuable option for people with cardiovascular disease, however, there ...

Home November 15, 2022
Home
UMSOM researchers display first genetically modified pig heart transplanted into living patient. Image courtesy of University of Maryland School of Medicine
News | Heart Failure
Unexpected Electrical Changes Seen in First Successful Transplant of Genetically-Modified Pig Heart

November 15, 2022 — Ten months after transplanting the first genetically-modified pig heart into a human patient ...

Home November 15, 2022
Home
When it comes to heart failure (HF), sex differences are known to impact everything from risk factors to clinical presentation to response to treatment, making sex a key factor to consider in studies of emerging pharmacotherapies.
News | Heart Failure
Study Shows Heart Failure Treatment With Dapagliflozin Consistently Benefited Both Men and Women

November 14, 2022 — When it comes to heart failure (HF), sex differencesare known to impact everything from risk factors ...

Home November 14, 2022
Home
Less complex heart patients may benefit, but not without risk
News | Pediatric Cardiology
Largest Randomized Trial Evaluates Steroids for Infant Heart Surgery

November 14, 2022 — For more than four decades, doctors have been split on whether giving steroids during a pediatric ...

Home November 14, 2022
Home
Reduction in the risk of death or major bleeding after primary PCI in patients with STEMI treated with heparin monotherapy (blue curve) or bivalirudin with a post-procedure infusion (red curve). The hazard ratio of 0.69 signifies a 31% reduction in risk. The ARR (absolute risk reduction) was 1.3%. The NNT (number of patients needed to treat to prevent one death or large bleed) was 76. Image courtesy of Mount Sinai Health System
News | Antiplatelet and Anticoagulation Therapies
Bivalirudin Found to be Safer and More Effective Than Heparin for Treating Heart Attack Patients Undergoing Percutaneous Coronary Intervention

November 14, 2022 — Bivalirudin is a safer and more effective anticoagulant than heparin for treating patients with the ...

Home November 14, 2022
Home
The "Trending Topics at Sessions 2022" panel of experts featured Manesh R. Patel, MD, FACC, FAHA, Chair of the Committee on AHA 2022 Scientific Sessions, to review highlights and lessons learned from the event.
News | AHA
AHA 2022 Trending Topics: Clinical Trials, Scientific Studies and AI

November 14, 2022 — The American Hospital Association Scientific Sessions 2022, held Nov. 5-7 in Chicago, IL, presented ...

Home November 14, 2022
Home
Investigators Compared AFib Patients Treated with Catheter Ablation to Those Treated with Anti-arrhythmic Drugs Only
News | Atrial Fibrillation
Study Finds Catheter Ablation Significantly Lowers Risk of Dementia in Patients with Atrial Fibrillation

November 10, 2022 — Biosense Webster, Inc., the global leader in cardiac arrhythmia treatment and part of Johnson & ...

Home November 10, 2022
Home
Cryoablation involves guiding a small tube into the heart and inflating a small balloon to kill problematic tissue with cold temperatures. Image courtesy of Medtronic
News | Atrial Fibrillation
National Study Suggests It's Time to Rethink How We Treat Atrial Fibrillation

November 10, 2022 — A national study led by UBC researchers at the Centre for Cardiovascular Innovation is shedding ...

Home November 10, 2022
Home
When the SARS-CoV-2 protein Nsp6 is made in a fruit fly heart (center), the heart has structural defects compared to a normal heart without the viral protein (left). When fruit fly hearts with the viral Nsp6 protein are given the metabolism changing drug 2DG (right), the hearts begin to look more normal than the ones with the viral protein that do not have the drug. Image courtesy of Zhe Han at UMSOM
News | Coronavirus (COVID-19)
How a SARS-CoV-2 Virus Protein Damages the Heart

November 10, 2022 — Researchers at the University of Maryland School of Medicine’s (UMSOM) Center for Precision Disease ...

Home November 10, 2022
Home
Findings from the BEST-CLI trial presented at the American Heart Association Scientific Sessions (AHA2022) indicate optimal treatment for patients with limb-threatening ischemia.  
News | AHA
BEST-CLI Clinical Trial Focuses on Optimal Treatment for Limb-Threatening Ischemia

November 10, 2022 ­– Significant findings from the clinical trial, known as “BEST-CLI — Best Endovascular versus Best ...

Home November 10, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now